Skip to main navigation Skip to search Skip to main content

IgLON5 antibodies are infrequent in patients with isolated sleep apnea

K. Hasselbacher, A. Steffen, K. P. Wandinger, N. Brüggemann*

*Corresponding author for this work
Original languageEnglish
JournalEuropean Journal of Neurology
Volume25
Issue number4
Pages (from-to)e46-e47
ISSN1351-5101
DOIs
Publication statusPublished - 01.04.2018

Funding

All participants are gratefully thanked for their invaluable participation. Dr Hassel-bacher has received personal fees and travel expenses from Inspire Medical Systems. Dr Steffen has received reimbursement of conference fees and travel and accommodation expenses, fees for preparing scientific continuing professional development or other events, funding for research he himself initiated, and fees for conducting clinical studies on related subjects from Inspire Medical Systems, Merz and Resmed. Dr Wandinger has nothing to declare. Dr Bru€ggemann was funded by the Collaborative Center for X-linked Dystonia-Parkinsonism and the German Research Foundation (BR 4328/2-1) and received speakers’ honoraria from the German Neurological Society. He received travel grants from Merz and St Jude Medical and a honorarium from Grünenthal.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Research Areas and Centers

  • Research Area: Medical Genetics

Cite this